ImCheck Therapeutics is a developer of immuno-modulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric, ovarian cancer cells and other solid solid tumours.

Biotechnology

Health Care

Therapeutics

ImCheck Therapeutics

Pierre d'Epenoux

Sophie Agaugué

Katrien Lemmens

Tracey Butler

Patrick BRUNE

Nabila Z.

Hans Henrik Chrois Christensen

Florence ALCARAZ

Emmanuel VALENTIN

Diane Delpy-Sampson

Claude Knopf

Carla Cano

Alem Truneh

Research and Development Team

Leadership Team

Finance and Administration Team

Teams at ImCheck Therapeutics

Research and Development Team

Leadership Team

Finance and Administration Team